Latham & Watkins advised CVC Capital Partners on CVC Fund VI’s acquisition of Teva Pharmaceutical Industries Ltd’s international women’s health assets. The new company, called Theramex,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
